Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Eli Lilly and Company
Woman and Man Max 99 years
Eli Lilly and Company
Update Il y a 4 ans
Open-Label Extension for Alzheimer’s Disease Patients Who Complete One of Two Semagacestat Phase 3 Double-Blind Studies (H6L-MC-LFAN or H6L-MC-LFBC)
The primary objective of the study is to assess the safety of semagacestat in Alzheimer’s disease patients during 24 months of open-label treatment following completion of up to 21 months of active tr...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Eli Lilly and Company
Update Il y a 4 ans
Study of the Safety and Efficacy in Chronic Kidney Disease Patients
To investigate the effect of LY2623091 on change from baseline in proteinuria after 3 weeks of daily oral dosing in CKD patients.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Eli Lilly and Company Limited
Update Il y a 4 ans
Duloxetine 60 to 120 mg versus Placebo in the Treatment of Patients with Osteoarthritis Knee Pain
To assess the efficacy of duloxetine 60 to 120 mg once daily (QD) compared with placebo on the reduction of pain severity as measured by the weekly mean of the 24-hour average pain scores in patients ...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Eli Lilly and Company Limited
Update Il y a 4 ans
An exploratory, prospective phase II study to investigate progression-free survival, response and overall survival seen with pemetrexed/cisplatin and the role of thymidylate synthase expression
The primary objective of this study is to determine the correlation between TS expression and PFS.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Eli Lilly and Company Limited
Update Il y a 4 ans
A Phase 2 Single-Arm Study of Gemcitabine in Combination with Oxaliplatin in Pediatric Patients with Relapsed or Refractory Neuroblastoma or Miscellaneous Solid Non-CNS Tumors
The primary objective is to assess the antitumor activity, as measured by objective response rate, of the gemcitabine plus oxaliplatin combination in pediatric patients with neuroblastoma. The antitu...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man
Between 18 years
and 99 years
Eli Lilly and Company
Update Il y a 6 ans
Étude I6F-MC-JJCD : étude de phase 1, évaluant la tolérance du LY3039478, un inhibiteur de Notch, associé à d'autres agents anti-cancéreux, chez des patients ayant un cancer avancé. [Informations issues du site clinicaltrials.gov et traduites par l'INCa]
Les tumeurs solides peuvent se développer dans n’importe quel tissu : peau, os, organes, etc. Ce sont les cancers les plus fréquents. Il existe plusieurs stades de cancers en fonction de la taille de ...
Country
France
organs
Tumeurs solides
Specialty
Thérapies Ciblées
Essai ouvert aux inclusions
More information
Woman and Man Max 99 years
Eli Lilly and Company
Update Il y a 4 ans
Evaluation of LY2951742 in the Prevention of Episodic Migraine
To test the hypothesis that at least 1 dose of LY2951742 is superior to placebo in the prevention of migraine headache in patients with episodic migraine.
Country
None
organs
None
Specialty
None
unknown
More information
Man Max 99 years
Eli Lilly and Company
Update Il y a 4 ans
A clinical trial looking at the use and safety of tadalafil for the treatment of Duchenne Muscular Dystrophy in children
The primary objective is to test the hypothesis that once daily tadalafil administered orally for 48 weeks lessens the decline in ambulatory ability as measured by the 6MWD compared to placebo in boys...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Eli Lilly and Company
Update Il y a 4 ans
Evaluation of LY2951742 in the Prevention of Chronic Migraine
To test the hypothesis that at least one dose of LY2951742 is superior to placebo in the prevention of migraine headache in patients with chronic migraine.
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Eli Lilly and Company Limited
Update Il y a 4 ans
A 24-Week Multicenter, Randomized, Open-Label, Parallel Group Study Comparing the Efficacy and Safety of Ixekizumab to Fumaric Acid Esters and Methotrexate in Patients with Moderate-to-Severe Plaque Psoriasis who are Naive to Systemic Treatment
The coprimary objectives of the study are to test whether ixekizumab Q2W/Q4W is superior to FAE and is superior to MTX at Week 24 in the treatment of patients with moderate-to-severe psoriasis who ar...
Country
None
organs
None
Specialty
None
unknown
More information
Previous
2
3
4
5
6
7
8
9
10
11
Next